β2-adrenoceptor function in the kidney

Folia Pharmacologica Japonica

Volumn 124, Issue 6, 2004, Pages 427-434

  Nakamura, Akio ^a   Imaizumi, Akira ^a   Yanagawa, Yukishige ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

2 adrenoceptor; Apoptosis; Cytokine; Renal function; Renal pharmacology

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CYTOKINE; SHIGA TOXIN; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; CYTOKINE PRODUCTION; GLOMERULUS FILTRATION RATE; HEMOLYTIC UREMIC SYNDROME; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY PROXIMAL TUBULE; NEPHRITIS; NEPHRON; NONHUMAN; RENAL ARTERY; REVIEW; SEPSIS; SMOOTH MUSCLE FIBER;

ADRENERGIC BETA-AGONISTS; ANIMALS; HUMANS; KIDNEY; RECEPTORS, ADRENERGIC, BETA-2;

EID: 10944239648     PISSN: 00155691     EISSN: None     Source Type: Journal    
DOI: 10.1254/fpj.124.427     Document Type: Review

References (58)

1. 2-adrenergic receptor mRNA expression along the hamster nephron segments. FEBS Lett. 1993;318:65-70.
2. Engel G, Maurer R, Perrot K, Richardson BP. β-Adrenoceptor subtypes in sections of rat and guinea-pig kidney. Naunyn Schmiedebergs Arch Pharmacol. 1985;328:354-357.
3. Murayama N, Ruggles BT, Gapstur SM, Werness JL, Dousa TP. Evidence for beta adrenoceptors in proximal tubules. Isoproterenol-sensitive adenylate cyclase in pars recta of canine nephron. J Clin Invest. 1985;76:474-481.
4. Summers RJ, Stephenson JA, Kuhar MJ. Localization of beta adrenoceptor subtypes in rat kidney by light microscopic autoradiography. J Pharmacol Exp Ther. 1985;232:561-569.
5. Boivin V, Jahns R, Gambaryan S, Ness W, Boege F, Lohse MJ. Immunofluorescent imaging of beta 1- and beta 2-adrenergic receptors in rat kidney. Kidney Int. 2001;59:515-531.
6. Healy D, Munzel P, Insel P. Localization of beta1- and beta2-adrenergic receptors in rat kidney by autoradiography. Circ Res. 1985;57:278-284.
7. 2-adrenoceptors in various human tissues. Life Sci. 1993;52:1063-1070.
8. Ariens EJ, Simonis AM. Physiological and pharmacological aspects of adrenergic receptor classification. Biochem Pharmacol. 1983;32:1539-1545.
9. Lubbecke F, Schneider D, Schutterle G. Regulation of adrenergic receptors in the rat kidney. J Pharm Pharmacol. 1993;45:1072-1076.
10. Emilien G, Maloteaux J-M. Current therapeutic uses and potential of beta-adrenoceptor agonists and antagonists. Eur J Clin Pharmacol. 1998;53:389-404.
11. Lazar-Wesley E, Hadcock JR, Malbon CC, Kunos G, Ishac EJ. Tissue-specific regulation of alpha 1B, beta 1, and beta 2-adrenergic receptor mRNAs by thyroid state in the rat. Endocrinology. 1991;129:1116-1118.
12. Silverman HJ, Penaranda R, Orens JB, Lee NH. Impaired beta-adrenergic receptor stimulation of cyclic adenosine monophosphate in human septic shock: Association with myocardial hyporesponsiveness to cathecholamines. Crit Care Med. 1993;21:31-39.
13. Bernardin G, Strosberg AD, Bernard B, Mattei M, Marullo S. β-Adrenergic receptor-dependent and-independent stimulation of adenylate cyclase is impaired during severe sepsis in humans. Intensive Care Med. 1998;24:1315-1322.
14. 2-Adrenoceptor activation attenuates endotoxin-induced acute renal failure. J Am Soc Nephrol. 2004;15:316-325.
15. Matsuda N, Hattori Y, Akaishi Y, Suzuki Y, Kemmotsu O, Gando S. Impairment of cardiac β-adrenoceptor cellular signaling by decreased expression of Gsα in septic rabbits. Anesthesiology. 2000;93:1465-1473.
16. Nijkamp FP, Engels F, Henricks PA, van Oosterhout AJ. Mechanisms of beta-adrenergic receptor regulation in lungs and its implications for physiological responses. Physiol Rev. 1992;72:323-367.
17. Guan Z, Miller SB, Greenwald JE. Zaprinast accelerates recovery from established acute renal failure in the rat. Kidney Int. 1995;47:1569-1575.
18. Schmidt W, Hacker A, Gebhard MM, Martin E, Schmit H. Dopexamine attenuates endotoxin-induced microcirculatory changes in rat mesentery: role of beta2 adrenoceptors. Crit Care Med. 1998;26:1639-1645.
19. Schelhammer JH, Marom Z, Kaliner M. Abnormal beta-adrenergic responsiveness in allergic subjects. II. The role of selective beta2-adrenergic hyporeactivity. J Allergy Clin Immunol. 1983;71:57-61.
20. Brodde OE. Beta-adrenoceptors in cardiac disease. Pharmacol Ther. 1993;60:405-430.
21. Robillard JE, Nakamura KT. Neurohormonal regulation of renal function during development. Am J Physiol. 1988;254:F771-F779.
22. Cohen ML, Berkowitz BA. Age-related changes in vascular responsiveness to cyclic nucleotides and contractile agonists. J Pharmacol Exp Ther. 1974;191:147-155.
23. Judes CJ, Helwig J, Bollack C, Mandel P. Isoproterenol-sensitive adenylate cyclase in glomeruli isolated from young and adult rat renal cortex. Gen Pharmacol. 1985;16:205-210.
24. 2-adrenoceptor agonist clenbuterol. Br J Pharmacol. 1987;90:601-607.
25. Pelayo JC, Tucker BJ, Blantz RC. Effects of beta-adrenergic stimulation with isoproterenol on glomerular hemodynamics. Am J Physiol. 1989;257:F866-F873.
26. Huber TB, Gloy J, Henger A, Schollmeyer P, Greger R, Mundel P, et al. Catecholamines modulate podocyte function. J Am Soc Nephrol. 1998;9:335-345.
27. 2-Adrenergic function in cultured rat proximal tubular epithelial cells. Am J Physiol. 1996;271:F71-F77.
28. 2- adrenoceptor function in cultured rat proximal tubular epithelial cells. Am J Physiol. 1997;273:F193-F199.
29. Kimmel PK, Goldfard S. Effects of isoproterenol on potassium secretion by the cortical collecting tubule. Am J Physiol. 1984;246:F804-810.
30. Tagoi K, Schuster VL, Stokes JB. Regulation of chloride self exchange by cAMP in cortical collecting tubule. Am J Physiol. 1986;251:F40-48.
31. Davies AO, Lefkowitz RJ. Corticosteroid-induced differential regulation of beta-adrenergic receptors in circulating human polymorphonuclear leukocytes and mononuclear leukocytes. J Clin Endocrinol Metab. 1980;51:599-605.
32. Hetier P, Ayala J, Bousseau A, Prochiantz A. Modulation of interleukin-1 and tumor necrosis factor expression by beta adrenergic agonists in mouse ameboid microgial cells. Exp Brain Res. 1991;86:407-413.
33. 2- adrenoceptor in the rat astrocytes. J Neuroimmunol. 1998;88:144-153.
34. Severn A, Rapson NT, Hunter CA, Liew FY. Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists. J Immunol. 1992;148:3441-3445.
35. Liao J, Keiser JA, Scales WE, Kunkel SL, Kluger MJ. Role of epinephrine in TNF and IL-6 production from isolated perfused rat liver. Am J Physiol. 1995;268:R896-R901.
36. 2-Agonists prevent Th1 development by selective inhibition of interleukin 12. J Clin Invest. 1997;100:1513-1519.
37. 2-adrenoceptor activation and angiotensin II on tumour necrosis factor and interleukin 6 gene transcription in the rat renal resident macrophage cells. Cytokine. 1999;11:759-765.
38. 2-Adrenoceptor agonist suppresses TNF-a production in rat mesangial cells. Cytokine. 2000;12:491-484.
39. 2-Adrenoceptor agonist suppresses renal tumour necrosis factor and enhances interleukin-6 gene expression induced by endotoxin. Nephrol Dial Transplant. 2000;15:1928-1934.
40. van der Poll T, Coyle SM, Barbosa K, Braxton CC, Lowry SF. Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin-10 production during human endotoxemia. J Clin Invest. 1996;97:713-719.
41. 2-adrenoceptor in endotoxin-stimulated renal macrophage. Kidney Int. 1999;56:839-849.
42. Olivier V, Parry GCN, Cobb RR, de Prost D, Mackman N. Elevated cyclic AMP inhibits NF-kappa B-mediated transcription in human monocytic cells and endothelial cells. J Biol Chem. 1996;271:20828-20835.
43. Tannenbaum CS, Hamilton TA. Lipopolysaccharide-induced gene expression in murine peritoneal macrophages is selectively suppressed by agents that elevate intracellular cAMP. J Immunol. 1989;142:1274-1280.
44. Seldon PM, Baenes PJ, Mega K, Giembycz MA. Suppression of lipopolysaccharide-induced tumour necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4. Mol Pharmacol. 1995;48:745-757.
45. 2-adrenoceptor prevents shiga toxin-induced tumour necrosis factor production. J Am Soc Nephrol. 2001;12:2288-2299.
46. Karin M. The regulation of the human tumour necrosis factor promoter region in macrophage, T cell, and B cell lines. J Biol Chem. 1995;270:16483-16486.
47. Zhong H, Su Yang H, Erdjument-Bromage H, Tempst P, Ghosh S. The transcriptional activity of NF-κB is regulated by the I-κB- associated PKAc subunit through a cyclic AMP-independent mechanism. Cell. 1997;89:413-424.
48. Yamakawa T, Eguchi S, Matsumoto T, Yamakawa Y, Numaguchi K, Miyata I, et al. Intracellular signaling in rat cultured vascular smooth muscle cells: role of nuclear factor-κB and p38 mitogen-activated protein kinase on tumor necrosis factor-α production. Endocrinology. 1999;140:3562-3572.
49. Baud L, Fouqueray B, Philippe C, Amrani A. Tumor necrosis factor alpha and mesangial cells. Kidney Int. 1992;41:600-603.
50. Gluser MP, Zanetti G, Baumgartner J-D, Cohen J. Septic shock: pathogenesis. Lancet. 1991;338:732-736.
51. Fouqueray B, Philippe C, Herbelin A, Perez J, Ardaillou R, Baud L. Cytokine formation within rat glomeruli during experimental endotoxemia. J Am Soc Nephrol. 1993;3:1783-1791.
52. 2- adrenoceptor agonist clenbuterol modulates Bcl-2, Bcl-xl and Bax protein expression following transient forebrain ischemia. Neuroscience. 1999;90:1255-1263.
53. 2-Adrenoceptor activation inhibits Shiga toxin2-induced apoptosis of renal tubular epithelial cells. Biochem Pharmacol. 2003;66:343-53.
54. Drucker DJ, Ehrlich P, Asa SL, Brubaker PL. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci USA. 1996;93:7911-7916.
55. Orlov SN, Thorin-Trescases N, Dulin NO, Dam TV, Fortuno MA, Tremblay J, et al. Activation of cAMP signaling trasiently inhibits apoptosis in vascular smooth muscle cells in a site upstream of caspase-3. Cell Death Differ. 1999;6:661-672.
56. Gu C, Ma YC, Benjamin J, Littman D, Chao MV, Huang XY. Apoptotic signaling through the beta-adrenergic receptor. A new Gs effector pathway. J Biol Chem. 2000;275:20726-20733.
57. Mühl H, Nitsch D, Sandau K, Brune B, Varga Z, Pfeilschifter J. Apoptosis is triggered by the cyclic AMP signalling pathway in renal mesangial cells. FEBS Lett. 1996;382:271-275.